SNGX READ THE FULL SNGX RESEARCH REPORT Business Update FLASH2 Trial Recommended to Stop for Futility On April 28, 2026, Soligenix, Inc. (NASDAQ: SNGX) announced interim results from the Phase 3 ...

Mercury reports on salary benchmarking for startups, emphasizing structured data for competitive and sustainable hiring ...

Cerebras Systems stock was down 3% premarket on Friday after surging more than 68% the previous day in a highly anticipated ...

Benchmark at South Farms, an Assisted Living and Mind & Memory Care community in Middletown, will host a complimentary three-part educational series in June for individuals and caregivers navigating ...

Issued on behalf of QSE — Quantum Secure Encryption Corp.Quantum Secure Encryption Corp. launches QPA v2 — an enterprise post-quantum ...

An unusually large in-the-money (ITM) put option tranche expiring over the next month in Taiwan Semiconductor (TSM), the ...

SAN DIEGO, CA / ACCESS Newswire / May 14, 2026 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp ...

Consolidated net revenue of € 713.4 million in the first quarter of 2026, +4.9% or +8.7% on a like-for-like basis(3) at constant exchange rates ...

Aptose Biosciences Inc. ("Aptose" or the "Company") (TSX: APS and OTC: APTOF), a clinical-stage precision oncology company developing a tuspetinib ...

Stock day trading is becoming more data-driven, faster, and more automated. In 2026, the best stock trading AI bots are not ...

Initiated enrollment of Phase 1 Study of PRT12396, mutant-selective JAK2V617F inhibitor in patients with polycythemia vera (PV) and myelofibrosis (MF) The Company expects to file the IND for PRT13722, ...

Q1’26 Revenue $72.8 millionQ1’26 Op Inc ($12.9) million loss due to revenue miss and staffing for Q3’26 growthConvertible ...